BackRigel Pharmaceuticals Overview

Rigel Pharmaceuticals Gross Profit

Gross Profit analysis for RIGL.

Quarterly Gross Profit

$54.21M
↑ 10.81% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$279.95M
↑ 53.78% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin